It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ENOV’s FA Score shows that 0 FA rating(s) are green whileINGN’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ENOV’s TA Score shows that 4 TA indicator(s) are bullish while INGN’s TA Score has 5 bullish TA indicator(s).
ENOV (@Medical/Nursing Services) experienced а +3.90% price change this week, while INGN (@Medical/Nursing Services) price change was +15.12% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +1.37%. For the same industry, the average monthly price growth was +2.38%, and the average quarterly price growth was +4.58%.
ENOV is expected to report earnings on Oct 30, 2025.
INGN is expected to report earnings on Nov 05, 2025.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
ENOV | INGN | ENOV / INGN | |
Capitalization | 1.69B | 202M | 836% |
EBITDA | -471.91M | -12.97M | 3,638% |
Gain YTD | -32.657 | -18.648 | 175% |
P/E Ratio | N/A | N/A | - |
Revenue | 2.15B | 340M | 632% |
Total Cash | 38.5M | 119M | 32% |
Total Debt | 1.46B | 19.2M | 7,599% |
ENOV | INGN | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 75 | 70 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 79 Overvalued | 82 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 95 | 93 | |
PRICE GROWTH RATING 1..100 | 84 | 55 | |
P/E GROWTH RATING 1..100 | 98 | 60 | |
SEASONALITY SCORE 1..100 | 50 | 90 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ENOV's Valuation (79) in the Industrial Machinery industry is in the same range as INGN (82) in the Medical Specialties industry. This means that ENOV’s stock grew similarly to INGN’s over the last 12 months.
ENOV's Profit vs Risk Rating (100) in the Industrial Machinery industry is in the same range as INGN (100) in the Medical Specialties industry. This means that ENOV’s stock grew similarly to INGN’s over the last 12 months.
INGN's SMR Rating (93) in the Medical Specialties industry is in the same range as ENOV (95) in the Industrial Machinery industry. This means that INGN’s stock grew similarly to ENOV’s over the last 12 months.
INGN's Price Growth Rating (55) in the Medical Specialties industry is in the same range as ENOV (84) in the Industrial Machinery industry. This means that INGN’s stock grew similarly to ENOV’s over the last 12 months.
INGN's P/E Growth Rating (60) in the Medical Specialties industry is somewhat better than the same rating for ENOV (98) in the Industrial Machinery industry. This means that INGN’s stock grew somewhat faster than ENOV’s over the last 12 months.
ENOV | INGN | |
---|---|---|
RSI ODDS (%) | 2 days ago63% | N/A |
Stochastic ODDS (%) | 2 days ago64% | 2 days ago76% |
Momentum ODDS (%) | 2 days ago63% | 2 days ago81% |
MACD ODDS (%) | 2 days ago69% | 2 days ago76% |
TrendWeek ODDS (%) | 2 days ago64% | 2 days ago76% |
TrendMonth ODDS (%) | 2 days ago73% | 2 days ago75% |
Advances ODDS (%) | 4 days ago60% | 4 days ago72% |
Declines ODDS (%) | 6 days ago75% | 2 days ago81% |
BollingerBands ODDS (%) | 2 days ago74% | 2 days ago81% |
Aroon ODDS (%) | 2 days ago67% | 2 days ago84% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBDIX | 131.35 | 1.59 | +1.23% |
Franklin Biotechnology Discovery A | |||
FIGRX | 58.60 | 0.31 | +0.53% |
Fidelity International Discovery | |||
PIEFX | 18.43 | N/A | N/A |
Federated Hermes Emerging Markets Eq IS | |||
NMUCX | 10.43 | -0.03 | -0.29% |
Neuberger Berman Multi-Cap Opp C | |||
FMCDX | 43.55 | -0.29 | -0.66% |
Fidelity Advisor Stock Selec Mid Cp A |
A.I.dvisor indicates that over the last year, INGN has been loosely correlated with VCYT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if INGN jumps, then VCYT could also see price increases.
Ticker / NAME | Correlation To INGN | 1D Price Change % | ||
---|---|---|---|---|
INGN | 100% | -2.74% | ||
VCYT - INGN | 46% Loosely correlated | +0.60% | ||
STRRP - INGN | 44% Loosely correlated | +0.75% | ||
CERS - INGN | 41% Loosely correlated | -2.36% | ||
OSUR - INGN | 39% Loosely correlated | -0.36% | ||
ENOV - INGN | 37% Loosely correlated | +2.53% | ||
More |